Work

P.244 Novel endpoints of motivation and reinforcement learning in a large interventional clinical trial of BI 425809 in patients with schizophrenia

Year: 2019

Type: article

Source: European Neuropsychopharmacology

DOI: 10.1016/j.euroneuro.2019.09.286

Authors: J. Podhorna, S. Hake, Y. Zhao, M. Groeschl, S. Pollentier, A. Atkins, R. Keefe

Institutions: Boehringer Ingelheim (Germany), Boehringer Ingelheim (Austria), Boehringer Ingelheim (United States), Verasci (United States), Duke Medical Center

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4250838057

FWCI:

Cites: 3

Cited by:

Related to: 10